undamentalytics Newsletter
Sign in

Lucid Diagnostics Inc. balance sheet

At the end of fiscal 2025, Lucid Diagnostics Inc. had total assets of $40.4m, total liabilities of $29.5m and shareholders' equity of $10.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents54221922——
Receivables000011
Inventory—00000
Total current assets572422253737
Total assets593327314039
Accounts payable111111
Total current liabilities4829242928
Total debt—014192424
Total liabilities4930253028
Shareholders' equity5523−251111
Net debt (negative = net cash)−54−22−5−4——
Shares outstanding70m—85m———

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: LUCD vs NRXSBIAF vs LUCDLUCD vs MCTA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Lucid Diagnostics Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Lucid Diagnostics Inc.